title: Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen.
abstract: Postmenopausal women who use tamoxifen present with an increased incidence of endometrial alterations, such as polyps and hyperplasia, in addition to a higher risk of malignant endometrial neoplasms. Among these endometrial changes, polyps are the most common, with a pathogenesis associated with hormonal influence. The objective of this study was to compare the expression of estrogen receptors (ERs) and progesterone receptors (PRs) in endometrial polyps from tamoxifen users with that in endometrial polyps and the atrophic endometrium of postmenopausal tamoxifen non-users. Among women undergoing surgical hysteroscopy, 84 tamoxifen users with benign endometrial polyps were selected. This group was compared to 84 samples of atrophic endometrium and to 252 benign polyps from postmenopausal women who were not treated with tamoxifen. The expression of ER/PR was assessed by immunohistochemical analysis, according to the percentage of stained cells, intensity of nuclear staining and final score. The polyps from tamoxifen users exhibited a higher expression of ER and PR in the glandular epithelium and stroma compared to the atrophic endometrium (P<0.0001). Compared to the polyps from women not treated with tamoxifen, tamoxifen users exhibited a higher PR expression in the epithelium (P=0.0014) and stroma (P=0.0056), with no difference in the expression of ER. In conclusion, endometrial polyps frequently exhibit an increase in ER expression, regardless of tamoxifen use. High levels of PR expression appear to be consistent with the estrogen agonist effects of tamoxifen.
authors.affiliation: Departments of Obstetrics and Gynecology, State University of Campinas (UNICAMP), Campinas, 13083-881 São Paulo, Brazil.
authors.forename: Rogerio Barros Ferreira
authors.initials: RB
authors.lastname: Leão
authors.affiliation: Pathological Anatomy, School of Medicine, State University of Campinas (UNICAMP), Campinas, 13083-881 São Paulo, Brazil.
authors.forename: Liliana
authors.initials: L
authors.lastname: Andrade
authors.affiliation: Pathological Anatomy, School of Medicine, State University of Campinas (UNICAMP), Campinas, 13083-881 São Paulo, Brazil.
authors.forename: Jose
authors.initials: J
authors.lastname: Vassalo
authors.affiliation: Departments of Obstetrics and Gynecology, State University of Campinas (UNICAMP), Campinas, 13083-881 São Paulo, Brazil.
authors.forename: Armando
authors.initials: A
authors.lastname: Antunes
authors.affiliation: Departments of Obstetrics and Gynecology, State University of Campinas (UNICAMP), Campinas, 13083-881 São Paulo, Brazil.
authors.forename: Aarão
authors.initials: A
authors.lastname: Pinto-Neto
authors.affiliation: Departments of Obstetrics and Gynecology, State University of Campinas (UNICAMP), Campinas, 13083-881 São Paulo, Brazil.
authors.forename: Lucia
authors.initials: L
authors.lastname: Costa-Paiva
keywords: endometrial polyp; estrogen receptor; progesterone receptor; tamoxifen